189 related articles for article (PubMed ID: 34890454)
1. Thrombin spatial distribution determines protein C activation during hemostasis and thrombosis.
Marar TT; Matzko CN; Wu J; Esmon CT; Sinno T; Brass LF; Stalker TJ; Tomaiuolo M
Blood; 2022 Mar; 139(12):1892-1902. PubMed ID: 34890454
[TBL] [Abstract][Full Text] [Related]
2. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
[TBL] [Abstract][Full Text] [Related]
3. Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.
Welsh JD; Poventud-Fuentes I; Sampietro S; Diamond SL; Stalker TJ; Brass LF
J Thromb Haemost; 2017 Mar; 15(3):526-537. PubMed ID: 27992950
[TBL] [Abstract][Full Text] [Related]
4. Relative antithrombotic and antihemostatic effects of protein C activator versus low-molecular-weight heparin in primates.
Gruber A; Marzec UM; Bush L; Di Cera E; Fernández JA; Berny MA; Tucker EI; McCarty OJ; Griffin JH; Hanson SR
Blood; 2007 May; 109(9):3733-40. PubMed ID: 17227834
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic efficacy in the guinea pig of a derivative of human protein C with enhanced activation by thrombin.
Kurz KD; Smith T; Wilson A; Gerlitz B; Richardson MA; Grinnell BW
Blood; 1997 Jan; 89(2):534-40. PubMed ID: 9002956
[TBL] [Abstract][Full Text] [Related]
6. Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound.
Muthard RW; Welsh JD; Brass LF; Diamond SL
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):645-54. PubMed ID: 25614284
[TBL] [Abstract][Full Text] [Related]
7. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin.
Li W; Zheng X; Gu J; Hunter J; Ferrell GL; Lupu F; Esmon NL; Esmon CT
J Thromb Haemost; 2005 Jul; 3(7):1351-9. PubMed ID: 15978090
[TBL] [Abstract][Full Text] [Related]
8. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
Diamond SL
Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
[TBL] [Abstract][Full Text] [Related]
9. The role of thrombin in haemostasis.
Al-Amer OM
Blood Coagul Fibrinolysis; 2022 Apr; 33(3):145-148. PubMed ID: 35239615
[TBL] [Abstract][Full Text] [Related]
10. Interrelationships between structure and function during the hemostatic response to injury.
Tomaiuolo M; Matzko CN; Poventud-Fuentes I; Weisel JW; Brass LF; Stalker TJ
Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2243-2252. PubMed ID: 30674670
[TBL] [Abstract][Full Text] [Related]
11. Potential role of recombinant factor VIIa as a hemostatic agent.
Hedner U; Erhardtsen E
Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
[TBL] [Abstract][Full Text] [Related]
12. Platelet-Inspired Intravenous Nanomedicine for Injury-Targeted Direct Delivery of Thrombin to Augment Hemostasis in Coagulopathies.
Girish A; Jolly K; Alsaadi N; de la Fuente M; Recchione A; An R; Disharoon D; Secunda Z; Raghunathan S; Luc NF; Desai C; Knauss E; Han X; Hu K; Wang H; Sekhon UDS; Rohner N; Gurkan UA; Nieman M; Neal MD; Sen Gupta A
ACS Nano; 2022 Oct; 16(10):16292-16313. PubMed ID: 35916497
[TBL] [Abstract][Full Text] [Related]
13. Experiences in Routine Genetic Analysis of Hereditary Hemorrhagic, Thrombotic, and Platelet Disorders.
Pezeshkpoor B; Oldenburg J; Pavlova A
Hamostaseologie; 2022 Oct; 42(S 01):S5-S12. PubMed ID: 35226963
[TBL] [Abstract][Full Text] [Related]
14. Role of Gly197 in the structure and function of protein C.
Lu Y; Biswas I; Villoutreix BO; Rezaie AR
Biochim Biophys Acta Gen Subj; 2021 Jun; 1865(6):129892. PubMed ID: 33722640
[TBL] [Abstract][Full Text] [Related]
15. Effect of activated human protein C on experimental venous thrombosis induced by stasis with operative invasion in mice.
Aoki Y; Fukumoto Y; Inoue K; Katsuura Y; Komoriya K; Miyamoto S
Arzneimittelforschung; 2000 Aug; 50(8):695-9. PubMed ID: 10994152
[TBL] [Abstract][Full Text] [Related]
16. Activated protein C inhibits thrombus formation in a system with flowing blood.
Lozano M; Escolar G; Schwarz HP; Hernández R; Bozzo J; Ordinas A
Br J Haematol; 1996 Oct; 95(1):179-83. PubMed ID: 8857957
[TBL] [Abstract][Full Text] [Related]
17. Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge.
Kowalska MA; Mahmud SA; Lambert MP; Poncz M; Slungaard A
Blood; 2007 Sep; 110(6):1903-5. PubMed ID: 17540840
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance.
Seré KM; Rosing J; Hackeng TM
Blood; 2004 Dec; 104(12):3624-30. PubMed ID: 15292065
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model.
Heeb MJ; Marzec U; Gruber A; Hanson SR
Thromb Haemost; 2012 Apr; 107(4):690-8. PubMed ID: 22370911
[TBL] [Abstract][Full Text] [Related]
20. Inherited abnormalities in the protein C activation pathway.
España F; Medina P; Navarro S; Estellés A; Aznar J
Pathophysiol Haemost Thromb; 2002; 32(5-6):241-4. PubMed ID: 13679649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
